Evaluation of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia
NCT00478985
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Myeloid Leukemia, Chronic
Interventions
BEHAVIORAL:
Imatinib ending
Sponsor
University Hospital, Bordeaux